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Abstract: Neuron-glia antigen 2-expressing glial cells (NG2 glia) serve as oligodendrocyte progenitors
during development and adulthood. However, recent studies have shown that these cells represent
not only a transitional stage along the oligodendroglial lineage, but also constitute a specific cell type
endowed with typical properties and functions. Namely, NG2 glia (or subsets of NG2 glia) establish
physical and functional interactions with neurons and other central nervous system (CNS) cell types,
that allow them to constantly monitor the surrounding neuropil. In addition to operating as sensors,
NG2 glia have features that are expected for active modulators of neuronal activity, including the
expression and release of a battery of neuromodulatory and neuroprotective factors. Consistently, cell
ablation strategies targeting NG2 glia demonstrate that, beyond their role in myelination, these cells
contribute to CNS homeostasis and development. In this review, we summarize and discuss the
advancements achieved over recent years toward the understanding of such functions, and propose
novel approaches for further investigations aimed at elucidating the multifaceted roles of NG2 glia.
Keywords: NG2 glia; oligodendrocyte progenitor cells; synapses; neuromodulation; neuroprotection;
cell ablation
1. Introduction
During central nervous system (CNS) ontogenesis, myelinating oligodendrocytes (OLs)
originate from parenchymal precursors expressing the neuron-glia antigen 2 (NG2) chondroitin
sulfate proteoglycan, and therefore, commonly referred to as oligodendrocyte precursor cells or
NG2-expressing glia (NG2 glia) [1]. These cells persist in the adult CNS parenchyma, where they
comprise about 5% of all CNS cells [2], and can serve as a rapidly responding reservoir for new
OLs in case of demyelination [1,3,4]. In intact adult nervous tissue, NG2 glia can also be engaged
in proliferation and maturation to sustain a certain degree of oligodendrogenesis [5,6] and myelin
plasticity [7–11]. Notably, recent in vivo longitudinal two-photon imaging studies showed that, in the
murine cortex, OL density continues to increase until two years of age [10], and more than half of
the OLs present in middle aged mice are produced during adult life (i.e., after fourmonths of age [9]).
The generation of such adult-born OLs is required to maintain proper axonal functions [12], and is
involved in the production of new myelin segments [9] and changes of the circuit properties subserving
experience-dependent plasticity (i.e., motor skills learning [7,8]). However, in both adult human and
rodent CNS, the density, distribution and proliferative rate of NG2 glia seem to be independent of
the presence/density of myelinated fibres. NG2 glia distribute homogenously throughout grey and
white matter parenchyma. Further, although gray matter cells have a longer cell cycle length than their
white matter counterparts [13], NG2 glia proliferative fractions do not differ in highly myelinated vs.
non-/poorly myelinated brain regions (i.e., the granular and the molecular layers of the cerebellum,
respectively; our unpublished observations). In intact conditions, most NG2 glia appear as “quiescent”
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cells (i.e., neither progressing along the lineage, nor re-entering the cell cycle), and overall, the fraction
of NG2 glia actively engaged in oligodendrogenesis is minimal [14,15]. These observations suggest
that in basal conditions such an abundant pool of resident NG2 glia may exert additional roles beyond
their functions in oligodendrogenesis and myelin production.
Although the molecular aspects of NG2 glia response to injury are far from being completely
understood, data accumulated so far indicate that, phenotypically, NG2 glia provide a stereotypic
reaction (i.e., increased NG2 expression, retraction of cell processes, cell body swelling, cell proliferation
and migration toward the lesion site) to almost all kind of injury, independently of the extent of
myelin loss [14,16–19]. Further, upon experimental demyelination in the subcortical white matter,
transient populations of NG2 glia coming from the subventricular zone (SVZ) of the lateral ventricles
immediately amplify and invade the lesion site, but ultimately seem not to contribute to myelin repair,
and are lost [20–22]. This indicates that the reactivity and amplification of NG2 glia (or at least of some
NG2 glia subsets) per se does not simply reflect a regenerative event. The post-injury emergence of
transient NG2 glia populations is reminiscent of the developmental scenario, where three waves of
NG2 glia are sequentially produced in the forebrain, and the first embryonically-generated cells are
entirely replaced during the first week of life [23]. The generation of such cell populations that do
not contribute to myelination suggests again that NG2 glia/glial subsets exert additional/alternative
functions in specific developmental/post-injury phases.
In line with this view, a subpopulation of NG2 glia has been observed to serve as multipotent
progenitors, producing protoplasmic astrocytes as well OLs in the embryonic ventral forebrain or
following some kinds of CNS injury [19,24–27]. It has also been proposed that adult NG2 glia may
activate spontaneous neurogenic events within restricted brain areas [28]. In view of achieving
neuronal replacement in the adult CNS, the idea that NG2 glia can be the source for new neurons
is particularly attractive because of their abundance and ubiquitous distribution. However, this has
been proven true in vivo only upon specific cell reprogramming approaches, and clear evidence
that adult NG2 glia spontaneously contribute to parenchymal neurogenesis or astrogliogenesis is
lacking [4,28–30].
Based on these and other findings, four years ago we proposed that, beyond sustaining
re-/myelination, NG2 glia may participate in the nervous tissue homeostasis, neuromodulation,
developmental and post-injury events [28]. Such a view has recently been substantiated by a growing
body of evidence, including descriptive observations and results of functional in vivo/in vitro studies.
Here, we summarize and discuss the advancements obtained in the field in the last years and propose
novel approaches for further investigations aimed at understanding the multifaceted roles of NG2 glia.
2. NG2 Glia Distribution, Self-Maintenance and Anatomical Relationships with Central Nervous
System Cells
Recent studies showed that NG2 glia distribution and density are tightly and homeostatically
regulated in adult CNS tissue. In vivo two-photon imaging analyses showed that NG2 glia processes
constantly survey their local environment with highly motile filopodia and growth cone-like structures
that retract upon contact with other NG2 cells [31,32]. As a result, NG2 glia are arranged in a
grid-like manner, where cells are equally spaced and, similar to astrocytes, occupy tridimensional
non-overlapping domains. In the mammalian and zebrafish CNS, NG2 glia division and short
distance migration are the mechanisms by which these cells maintain their uniform density in
space and time: once an individual NG2-expressing cell is “lost” because of maturation (i.e., loss of
progenitor features including expression of cell surface signal molecules) or experimental ablation, a
neighboring NG2 cell enters the cell cycle and migrate to fill the unoccupied space (Figure 1A) [31–34].
Notably, similar to stem cells, NG2 glia can divide asymmetrically in vivo and give rise to a mixed
progeny, either keeping a progenitor phenotype or proceeding to differentiation (Figure 1B) [5,6,35].
This mechanism may allow the generation of OLs, while preventing the progressive exhaustion of NG2
glia during adulthood. NG2 glia maintenance is also regulated by specific synapse-mediated signals
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received from γ-aminobutyric acid (GABA)-ergic neurons (see also below), as demonstrated by the
progressive depletion of the NG2 glia pool lacking the GABA-A receptor subunit γ2 [36]. The discovery
of such efficient—and somehow redundant—regulation mechanisms by which a constant population
of NG2 glia is homeostatically maintained in time and space, even in non-/poorly-myelinated CNS
regions, challenges the assumption that NG2 glia exclusively serve as progenitors for new OLs, and
suggests functions related to the surveillance and modulation of the activity of the surrounding
neuropil, as formerly assessed for astrocytes and microglia [37–40].
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Figure 1. Schematic representation of the mechanisms assuring NG2 glia maintenance and of their 
physical interactions with neurons and other central nervous system (CNS) cell types (A) NG2 glia 
are distributed in a grid-like manner and occupy non-overlapping domains. When an individual 
NG2-expressing cell is lost, a neighboring NG2 cell divide and migrate to fill the unoccupied space. 
(B) In the adult and juvenile cortex, NG2 glia can divide asymmetrically and give rise to a mixed 
progeny either keeping a progenitor phenotype or proceeding to differentiation. (C) NG2 glia 
establish physical contacts with neuronal dendrites, somata, nodes of Ranvier and synapses. NG2 glia 
and astrocytes often contact the same node of Ranvier or synapse, but the relative processes show 
distinct localization. NG2 glia also receive functional synaptic contacts from unmyelinated axons and 
axonal terminals. In the adult CNS, NG2 glia display a perivascular distribution or extend some 
processes to physically interact with pericytes and blood vessels. NT: Neurotransmitter; OL: 
Oligodendrocyte. 
In line with this view, confocal and electron microscopy studies showed that NG2 glia establish 
physical contacts with functionally relevant neuronal domains, including dendrites [41,42], somata 
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rogeny either keeping a progenitor phenotype or proceeding to differentiation. (C) NG2 glia establish
physical contacts with neuronal dendrites, somata, nodes of Ranvier and synapses. NG2 glia and
astrocytes often contact the same node of Ranvier or synapse, but the relative processes show distinct
localization. NG2 glia also receive functional synaptic contacts from unmyelinated axons and axonal
terminals. In the adult CNS, NG2 glia display a perivascular distribution or extend some processes to
physically interact with pericytes and blood vessels. NT: Neurotransmitter; OL: Oligodendrocyte.
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In line with this view, confocal and electron microscopy studies showed that NG2 glia
establish physical contacts with functionally relevant neuronal domains, including dendrites [41,42],
somata [14,41,43,44], nodes of Ranvier [45,46] and synapses [47,48] (Figure 1C). About 30–50% of the
nodes are contacted by both NG2 glia and astrocyte processes in the optic nerve, corpus callosum,
and spinal cord of young adult rodents. Ultrastructural analyses revealed that NG2 glia processes
extend fine, finger-like projections that contact the nodal membrane at discrete points, while astrocytes
had broader processes that surround the entire nodes [46] (Figure 1C). Similarly, NG2 glia and
astrocytes often contact the same axon terminals, with NG2 glia thin processes interdigitating between
the pre- and post-synaptic elements and large astrocytic processes ensheating the entire synapses [41,47]
(Figure 1C). These observations suggest different roles of the contacts established by the two glial cell
types at nodes and synaptic sites.
What makes NG2 glia unique among the glial cells is their connections with neurons through
unidirectional neuron-to-NG2 glia synapses. Most, if not all NG2 glia in the grey and white
matter receive functional glutamatergic and/or GABAergic synaptic contacts, whose machinery
and ultrastructure is remarkably similar to that of conventional neuron-to-neuron synapses.
Such organization includes the tight alignment of neuron and NG2 glia cell membranes, the presence
of an active zone with accumulation of synaptic vesicles on the neuronal side, and an electron dense
postsynaptic density on the NG2 cell side. Notably, neuron-to-NG2 glia synapses are established
in parallel with neuronal synaptogenesis [14,49], and are lost during NG2 glia progression in
maturation [48,49]; this is in line with a specific role of this form of communication in undifferentiated
NG2 glia. Remarkably, while glutamatergic neuron-to-NG2 glia synapses usually derive from
long-range axons impinging almost exclusively on NG2 glia processes [50–52], GABAergic synapses
derive from local interneurons [49,53] with a specific distribution of the synaptic contacts from
fast spiking (located at NG2 glia somata and proximal parts of the processes) and non-fast spiking
interneurons (located at the distal parts of NG2 glia processes) [49]. Although both glutamatergic and
GABAergic neuron-to-NG2 glia synaptic inputs induce depolarization (since the measured chloride
reversal potential in these cells is around −30/−40 mV), such well-defined arrangement suggests
distinct roles for the different types of synapses impinging onto NG2 glia. In line with this idea,
while the glutamatergic inputs onto NG2 glia increase in frequency and amplitude during CNS
maturation [54], at least in the cerebral cortex, GABAergic neuron-to-NG2 glia synaptic transmission is
a phenomenon restricted to developmental stages [49,55].
Intimate physical interactions also occur between NG2 glia and astrocytes [56,57], microglia [58],
and myelinating OLs. Notably, while NG2 glia are never coupled via gap-junctions [59,60], some of them
express connexin 32 [61] and partly couple to mature OLs [62]. Further, electron microscopy analysis
showed that NG2 glia processes often contact the paranodal loops of myelin [46]. These data suggest a
privileged communication between NG2 glia and other elements in the oligodendroglial lineage.
In the embryonic mouse and human brain, NG2 glia are closely associated with the developing
blood vessels, by being either positioned at the sprouting tip or tethered along the abluminal surface
of the endothelium via the basal lamina [63,64]. Some populations of NG2 glia maintain a perivascular
distribution also in the mouse neonatal brain and adult white matter [65–68]. In such perivascular
niche, NG2 glia establish direct interactions through their processes or somata with both endothelial
cells and pericytes. Beside these perivascular NG2 glia, a large fraction of parenchymal NG2 cells,
whose somata are located away from blood vessels, extend some processes to physically interact with
pericytes and microvessels [41,46] (Figure 1C). Such a distribution suggests some form of crosstalk
among NG2 glia, endothelial cells and pericytes (see below).
3. NG2 Glia as Sensors of Neuronal Activity
NG2 glia contacts/contiguity with functionally relevant neuronal domains put them in a strategic
position to monitor the activity of neuronal circuitries, integrate distinct inputs, and possibly respond to
changes of the firing patterns of the surrounding neurons [69]. Indeed, a number of studies have shown
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that NG2 glia dynamically react to alterations in neurotransmission [70]. Pioneer experiments have
shown that suppression of neural activity due to intraocular injection of tetrodotoxin (TTX) remarkably
reduces NG2 glia proliferation in the optic nerve [71]. Consistently, deprivation of sensory experience
(i.e., whisker removal at developmental stages) negatively affects NG2 glia proliferation and survival,
and alters their distribution in the somatosensory cortex [6,52]. In contrast, electrical stimulation of the
corticospinal tract promotes NG2 cell proliferation and differentiation in the adult rat [72]. Similarly,
neuronal activity induced by optogenetic stimulation in Thy1-channelrhodopsin-2 transgenic mice,
elicits a mitogenic response in NG2 glia and increases their differentiation [73]. Again in line with
an activity-dependent regulation of the number of NG2 glia and OLs, increased rates of NG2 glia
proliferation have been observed in response to wheel running and environmental enrichment [74].
However, in later studies, voluntary physical exercise has instead been reported as being accompanied
by a reduction of the proliferation rate, premature differentiation, and changes in NG2 glia division
modality in the adult mouse brain [5,75,76]. Indeed, a recent study showed that the pattern of neuronal
activity, rather than just the presence or absence of activity, determines the activity-dependent behavior
of NG2 glia in vivo. By implanting an electrode array into the corpus callosum of adult mice, Nagy
and colleagues [77] showed that NG2 glia respond differently when callosal axons are stimulated at 5,
25 or 300 hertz (Hz). Namely, stimulation at 5 Hz promoted NG2 glia maturation, while stimulation at
25 or 300 Hz stimulated NG2 glia proliferation. These findings are particularly noteworthy, because the
rate and timing of neuronal firing are the main carriers of information about the features of a task or
stimulus, and also because they imply that NG2 glia are somehow capable of discriminating between
different patterns of neuronal firing (see below).
How do NG2 glia sense neuronal activity? Indeed, another feature that makes NG2 glia unique
among glial cells is the expression of a large repertoire of typically “neuronal” proteins, including
ion channels and neurotransmitter receptors. These comprise Ca2+-permeable and impermeable
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionicacid (AMPA) and N-methyl-D-aspartate (NMDA)
ionotropic glutamate receptors; group I (mGluR1 and mGluR5), group II (mGluR3) and group
III (mGluR4) metabotropic glutamate receptors; ionotropic and metabotropic GABA receptors;
Ca2+-permeable and impermeable nicotinic acetylcholine receptors (nAChRs); muscarinic acetylcholine
receptors (mAChRs); ionotropic glycine receptors (GlyRs); adrenergic, dopamine, serotonin and
purinergic receptors [78]. The expression of these receptors is not universal in NG2 cell populations
(e.g., only 60% of the callosal NG2 cells are able to respond to NMDA [79]), indicating a certain
degree of heterogeneity within NG2 glia as regards their potential to sense and respond to changes in
neurotransmission. Despite the fact that some of these neurotransmitter receptors (i.e., AMPA and
ionotropic GABA receptors) have been shown to mediate neuron-to-NG2 glia synaptic communication,
activation of most of them is thought to occur through extrasynaptic mechanisms [48], and is associated
with large, widespread intracellular Ca2+ elevations [78].
Beside such activity-dependent “paracrine” interactions with neurons, studies show that NG2
cells are particularly well-suited for exerting a more tight and precise monitoring of the surrounding
neuropil. First, NG2 glia are physically integrated in neuronal circuitries, since they receive
synapses from collaterals of axons simultaneously impinging on nearby excitatory or inhibitory
neurons [50,51,54]. Thus, by receiving paired/synchronous synaptic signals, NG2 glia can operate
a real-time control of the incoming inputs onto surrounding neurons. Further, the expression of
high levels of “leak” potassium channels and the connection with neurons through conventional
synapses make NG2 glia able to sense even small changes in neuronal activity with an extremely
high temporal and spatial resolution. Of note, NG2 glia have been reported to detect fine changes of
extracellular potassium concentration due to the discharge of a single neuron via the inward-rectifier
Kir4.1 potassium channels [78,80]. Similarly, by employing two-photon-based glutamate uncaging to
produce very localized and brief release of glutamate onto NG2 glia processes segments, Sun et al. [81]
showed that small neurotransmitter release events at neuron-to-NG2 cell synapses can be sensed via
the generation of local depolarizations and, consequentially, local Ca2+ signals in NG2 glia processes.
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The incoming electrical synaptic inputs are temporally and spatially summed and integrated by NG2
glia, by using Ca2+ levels to proportionally encode the number of the active synapses [81]. Interestingly,
by analysing the properties of ionic currents elicited by repetitive axonal stimulation at glutamatergic
neuron-to-NG2 glia synapses, Nagy et al. [77] recently demonstrated that, similar to neurons, NG2
glia are also able to discriminate different patterns of presynaptic axonal activity (i.e., stimulation
trains with distinct frequency of pulses). Since in neurons different patterns of incoming inputs induce
Ca2+ signals with distinct temporal and spatial distribution and the activation of diverse signaling
pathways, such discriminative ability is thought to subserve the engagement of NG2 glia in either
proliferation or differentiation following stimulation at different frequencies [77].
On the whole, these findings indicate that NG2 glia are specialized “listeners and integrators” of
neuronal activity, and adjust their behavior in response to its changes. In this context, intracellular
Ca2+ transients—generated in different spatial domains of NG2 glia depending on the pattern/type of
incoming activity (including synaptic and extrasynaptic inputs)—likely serve distinct roles. Namely,
large Ca2+ signals involving the entire cell arborization and soma are particularly apt to induce
gene expression changes and global cellular actions such as cell division, differentiation, survival or
motility [78]. Conversely, beyond allowing the integration of the synaptic activity received by distinct
axons, Ca2+ transients restricted to specific segments of individual processes may be implicated in
more compartmentalized functions, such as the stabilization of contacts between NG2 glia processes
and axons [82,83], process motility [31], local protein synthesis [84,85], or secretion. Indeed, NG2 glia
produce a wide range of “neuroactive” factors, and the release of some of them is activity-dependent
(see below). This suggests that the integration of NG2 glia in neuronal circuitries and their exquisite
ability to perceive activity changes/patterns may be instrumental for a neuron-to-NG2 glia-to-neuron
communication loop contributing to homeostasis and/or plasticity.
4. Maintenance of NG2 Glia Is Required for Central Nervous System Homeostasis and
Development
To unveil the specific contribution of NG2 glia to CNS functions/ontogeny, a wide range of
approaches have been developed to study the consequences of their selective ablation from the adult or
developing brain. Pioneer studies have exploited the exposure to high-doses of X-rays or the infusion
of mitotic blockers (such as Arabinofuranosyl cytidine (AraC)) to ablate cycling cells, including NG2
glia. These approaches lacked cell-type specificity and suffered from side-effects, making it difficult
to attribute a phenotype exclusively to NG2 glia loss. Thus, in the most recent studies, NG2 glia
ablation has been achieved by the generation of mouse lines expressing a “suicide” gene under a NG2
glia specific promoter. Suicide genes typically encode for an essential protein, for a toxin, or for an
enzyme that converts an exogenous drug into a toxic agent [86]. Of note, in all cases the effectiveness
of the control mechanisms by which NG2 glia density/distribution are maintained in space and time
hampered a long-lasting NG2 glia ablation. Even in the most efficient systems, cells escaping the
ablation immediately reacted, entering the cell cycle and replacing the lost cells. Thus, no study has
succeeded so far in ablating NG2 glia for long periods, and available data only refer to phenotypes
emerging from transient NG2 glia loss. However, despite this limitation, ablation strategies provided
important evidence for a NG2 glia specific contribution in CNS physiology and development, beyond
their role as OL progenitors.
By using a transgenic mouse model expressing the diphtheria toxin receptor (DTR) under the
control of the NG2 promoter (NG2Cre-R26DTR mice), Birey and colleagues [87] showed that the
selective ablation of about 50% of NG2 glia in adult mice caused deficits in the glutamatergic
neurotransmission (i.e., decreased amplitude and increased decay of the miniature excitatory
postsynaptic currents (mEPSC), and an altered postsynaptic glutamate receptor trafficking in pyramidal
excitatory neurons), negatively affected the astrocytic extracellular glutamate uptake, and induced
depressive-like behaviors in mice. Of note, these effects could be observed only in the prefrontal cortex.
No changes were observed in the dorsal striatum, while different electrophysiological phenotypes have
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been found in the somatosensory cortex (where both mEPSC frequency and decay were increased),
indicating a differential contribution of NG2 glia in the regulation of glutamatergic neurotransmission
in distinct brain regions. By using this ablation strategy, NG2 glia loss did not result in brain vasculature
alterations, inflammation, microglia activation, or neurodegeneration [87].
Conversely, in a transgenic rat model expressing thymidine kinase (TK) (that converts the prodrug
ganciclovir into a toxic triphosphate molecule that can be incorporated into the genome during
DNA synthesis, leading to the selective ablation of proliferative cells) under the NG2 promoter,
Nakano et al. [88] found that NG2 glia loss induced neurodegeneration, microglia activation and
neuroinflammation in the adult hippocampus. Reduced levels of the immunomodulatory factor
hepatocyte growth factor (HGF) have been proposed to mediate such effects. The different outcomes of
NG2 glia ablation in the two studies may be interpreted again as the result of the loss of region-specific
functions exerted by NG2 glia, or may be related to the different extent and timing of cell ablation
(about 50% of NG2 glia in the cortex after seven days in [87]; about 80% in the hippocampus after
one day in [88]). Milder effects reported in Birey et al. [87] may be indicative of the persistence of
a sufficient number of NG2 glia contributing to neuronal support in the mouse cortex. However,
even in those regions where NG2 ablation reached higher percentages (i.e., 80% in the subcortical
white matter and 90% in the striatum after seven days), no sign of neurodegeneration was detected
in NG2Cre-R26DTR mice. An alternative explanation could be that the huge mass of NG2 glia
simultaneously undergoing cell death in [88] may have triggered a robust microglia response that
eventually impacted on hippocampal neuron survival per se (i.e., independently of the possible effects
of NG2 glia loss); further studies will clarify this issue. In any case, the inconsistency of the results of
these two studies points to the intrinsic limitations of all cell ablation approaches, that must be taken
into account in the interpretation of the results obtained by these experimental strategies.
A third recent study [42] used three different methods (i.e., X-irradiation, AraC infusion into the
third ventricle and a novel mouse line where Esco2, a protein necessary for cell cycle progression,
could be deleted in NG2 glia, inducing cell death in cycling NG2 cells; see also [12]) to ablate NG2
glia in the adult mouse median eminence. Here, NG2 glia ablation caused the degeneration of the
dendrites of hypothalamic neurons expressing the leptin receptor. This led to the loss of neuronal
responsiveness to leptin, and consequentially, to mouse overeating and obesity. These data showed
a specific NG2 glia contribution to the body weight control, likely exerted by providing trophic or
structural support to neuronal dendrites.
Cell ablation strategies have also been used to investigate NG2 glia roles during CNS ontogenesis.
Recently, Minocha et al. [63] developed two Cre-mouse lines expressing a ’floxed’ diphtheria toxin gene
under either the Nkx2.1 (Nkx2.1-Cre -R26DTA) or the NG2 (Cspg4-Cre-R26DTA) promoter to ablate
the first wave of NG2 glia produced in the forebrain during the embryonic life. In the mouse, these cells
originate at E12.5 from Nkx2.1-expressing progenitors of the medial ganglionic eminence and anterior
entopeduncular area, and transiently populate the entire telencephalon by E14.5 before disappearing
at around postnatal day eight (P8) [84,89,90]. Thus, they do not contribute to myelination and their
transient nature raises numerous questions about their possible role/s during CNS development.
Interestingly, the ablation of such first wave of NG2 glia severely affected the formation of the blood
vessel network by reducing vascular ramifications and connections during the embryonic life. Of note,
analyses at postnatal stages did not reveal any such defects, indicating compensatory proangiogenic
actions of later appearing NG2 glia or other cell types.
In another study, the ablation of NG2 glia in a transgenic myelin basic protein (MBP)-TK mouse
line during the early phases of postnatal development (i.e., at P1) resulted in a rapid increase of
axonal sprouting in the cerebellum, changes in the expression of molecules involved in axon plasticity
and guidance (i.e., increased levels of the growth-associated protein GAP43, reduced expression of
Semaphorin 3a and Netrin 1), and altered localization and function of ionotropic glutamate receptors
in Purkinje neurons [91]. These studies showed that during the postnatal and embryonic life, NG2 glia
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populations are engaged in developmental events well before the onset of myelination, and indicated
their active participation in shaping neuronal circuits and blood vessel networks.
5. NG2 Glia-Derived Signals Can Modulate Neuronal and Non-Neuronal Cell Functions in the
Central Nervous System
Traditionally, NG2 glia have been considered only as a target for factors produced by neighboring
cells: a large repertoire of paracrine signals produced by neurons, astrocytes, microglia, and endothelial
cells has been shown to influence NG2 glia during myelination and after injury [68,92]. However,
accumulating evidence shows that, depending on the context, NG2 glia can serve as a source for a
plethora of secreted molecules which are able to support or interfere with the functions of other CNS
cell types. Namely, Sypecka and Sarnowska [93] reported a neuroprotective effect of rat NG2 glia
conditioned medium (CM) on organotypic hippocampal slices subjected to oxygen-glucose deprivation.
Consistently, rat embryonic cortical neurons showed a marked increase in survival when co-cultured
with NG2 glia or exposed to their CM [94,95]. Further, the CM of NG2 glia displayed remarkable
pro-angiogenic effects by stimulating proliferation, tip sprouting, tube formation, and expressions
of tight-junctions proteins in endothelial cells [65,96,97] and promoting proliferation/survival of
pericytes [66]. In contrast, the CM obtained from NG2 glia exposed to inflammatory cytokines
weakened endothelial barrier tightness in vitro [67]. These findings indicated that, overall, NG2 glia
can provide functionally relevant paracrine signals. However, mechanistic insights about (i) their
molecular identity, (ii) the spatio-temporal regulation of their production/release, and (iii) their
targeting and relevance in vivo, started to be unveiled only very recently. Indeed, the physical
apposition of the tiny NG2 glia processes at specific sites of neuronal and non-neuronal CNS cells
suggests a focal release and a precise targeting of NG2 glia-derived signals. Synaptophysin-positive
clusters indicative of a ‘classical’ secretory vesicle accumulation and release machinery have been
observed at defined sites along the NG2 glia processes [41]. Other mechanisms of signal transfer have
been also reported, including cleavage of fragments of membrane-bound molecules [98] or exosome
shedding [99]. Signal transfer through exosomes allows cell-specific targeting by receptor-ligand
interactions [100] and assures that a well defined concentration of the signal may be delivered to the
target. Thus, this latter form of communication again suggests a specific control of the distribution and
intensity of the biological effects elicited by NG2-derived signals.
As regards the molecular identity of NG2 glia secreted factors, in vitro/in vivo analyses of
gene expression or of NG2 glia CM showed that they include growth factors, neurotrophins,
neuromodulatory and neurosupportive signals, cell adhesion and extracellular matrix (ECM) molecules,
matrix metalloproteases and metalloprotease inhibitors, inflammatory cytokines/immunomodulatory
factors, morphogens (Table 1).
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Table 1. List of the signals produced/released by NG2 glia.
Type of Signal Name and Abbreviation Exp. Approach (Source) Function
Growth factors
Fibroblast growth factor 2, FGF2 Gene expr. study of cultured mouse NG2 glia and expr. inadult mouse NG2 glia in vivo [87]
NG2 glia modulation of glutamatergic neurotransmission and astrocytic
extracellular glutamate uptake [87], neuronal protection and CNS
repair [101], modulation of synaptic plasticity [102] and astroglial and
microglial reactivity [103]
Platelet-derived growth factor AA, PDGF-AA CM of cultured mouse NG2 glia [97] Neuronal protection [104], synaptic plasticity [105] and angiogenesis [106]
Platelet-derived growth factor BB, PDGF-BB CM of cultured mouse NG2 glia [97] Neurotrophic and neuroregulatory functions [107], synaptic plasticity [105]
Vascular endothelial growth factor, VEGF CM of cultured mouse NG2 glia [97] Neurotrophic function [108,109], regulation of adult neurogenesis [108]
Insulin-like growth factor 1, IGF-1 CM of cultured rat NG2 glia [94];Gene expr. study of cultured rat NG2 glia [93] Synaptic maturation [110]
Hepatocyte growth factor, HGF In vivo expr. in rat NG2 glia [88];Protein expr. in cultured rat NG2 glia [111] Neuronal plasticity [112]
Neurotrophins
Brain derived growth factor, BDNF
CM of cultured rat NG2 glia and protein expr. in adult mouse
NG2 glia in vivo [113];
CM of cultured human NG2 glia [114];
Gene expr. study and CM of cultured rat NG2 glia [93]
Neurotrophic function, neurotransmitter modulation and in neuronal
plasticity [115]
Nerve growth factor, NGF Gene expr. study of cultured mouse NG2 glia [87,116] Neurotrophic function, brain plasticity [117]
Neurotrophin-3, NT-3 CM of cultured human NG2 glia [114];Gene expr. study of cultured rat NG2 glia [93] Neurotrophic function, neuronal survival and differentiation [118,119]
Neurotrophin 4/5, NT-4/5 Gene expr. study of cultured mouse NG2 glia [87] Neurotrophic function, neuronal survival and differentiation [120]
Glial cell-derived neurotrophic factor, GDNF Gene expr. study of cultured mouse NG2 glia [87];Gene expr. study of cultured rat NG2 glia [93]
Neurotrophic function, survival and morphological differentiation of
dopaminergic neurons [121]
Ciliary neurotrophic factor, CNTF Gene expr. study of cultured rat NG2 glia [93] Neuronal and oligodendroglial survival [122–124]
Cell adhesion and
extracellular matrix
molecules
Neuronal cell adhesion molecule, NrCAM Gene expr. study of freshly sorted adult human NG2 glia [125] Maintenance of Na+ channels at nodes of Ranvier [126], dendritic spineremodelling [127]
NCAM Gene expr. study of freshly sorted adult human NG2 glia [125] Neuronal plasticity [128], neuritogenesis and synaptogenesis [129], adultneurogenesis [130]
Down Syndrome Cell Adhesion
Molecule, Dscam
Gene expr. study of freshly sorted mouse NG2 glia [131] and
freshly sorted adult human NG2 glia [125] Neurite repulsion [132–135]
Chondroitin sulphate proteoglycan4,
Cspg4/NG2
Gene expr. study of freshly sorted adult human NG2
glia [125,136]
Modulation of synaptic activity and action potential conduction [137],
axonal guidance and regenerative processes [138]
Versican, Vcan Gene expr. study of freshly sorted adult human NG2 glia [125]and freshly sorted mouse NG2 glia [131] Assembly, maintenance and function of the nodes of Ranvier [139]
Brevican Gene expr. study of freshly sorted mouse NG2 glia [131] Assembly, maintenance and function of the nodes of Ranvier [140]
Tenascins Gene expr. study of freshly sorted adult human NG2 glia [125];Gene expr. study of freshly sorted mouse NG2 glia [131] Synaptic plasticity [141]
Glypican 5, Gpc5 Gene expr. study of freshly sorted mouse NG2 glia [131] Neuronal plasticity [142,143]
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Table 1. Cont.
Type of Signal Name and Abbreviation Exp. Approach (Source) Function
Cell adhesion and
extracellular matrix
molecules
Emilin And Multimerin Domain-Containing
Protein 1, Emid1 Gene expr. study of freshly sorted mouse NG2 glia [131] Blood vessel maintenance [144]
Syndecan 3, sdc3 Gene expr. study of freshly sorted adult human NG2 glia [125] Synaptic plasticity [145]
Spondin 1, Spon1 Gene expr. study of freshly sorted mouse NG2 glia [131] Neural cell adhesion and neurite outgrowth [146]
Thrombospondin 2 and 4 Gene expr. study of freshly sorted adult human NG2 glia [125] Synaptogenesis and synaptic plasticity [147], inflammatory response andrepair of the blood brain barrier [148]
Cerebellin 1, cbln 1 Gene expr. study of cultured mouse NG glia [87] Synaptic organizer, synapse integrity and synaptic plasticity [149,150]
SPARC-Related Modular Calcium-Binding
Protein 1, SMOC1 Gene expr. study of freshly sorted mouse NG2 glia [131] Angiogenesis [151]
Olfactomedin 2, Olfm2 Gene expr. study of freshly sorted mouse NG2 glia [131] Synaptogenesis and synaptic plasticity [152]
Neurexophilin 1, Nxph1 Gene expr. study of freshly sorted mouse NG2 glia [131] Synaptogenesis and synaptic plasticity [150,153]
Neuronal Pentraxin 2, Nptx2 Gene expr. study of freshly sorted mouse NG2 glia [131] and ofcultured and freshly sorted mouse NG2 glia [154]
Synaptogenesis and synaptic plasticity [150,153,155,156], trafficking of
glutamate receptors [157]
Matrix metalloproteases
and metalloprotease
inhibitors
Matrix Metalloprotease 3, MMP3
CM of cultured mouse NG2 glia [26];
Gene expr. study of cultured mouse NG2 glia exposed to Il17
or Tnf [158]
Neuronal and synaptic plasticity [159]
Matrix Metalloprotease 9, MMP9
CM of cultured mouse NG2 glia [26];
CM of cultured rat NG2 glia and protein expr. in mouse NG2
glia in vivo—adult white matter [67]
Gene expr. study of cultured mouse NG2 glia exposed to Il17
or Tnf [158]
Blood vessel remodeling after white matter injury [160]. Remodeling of
synaptic networks in adult brain [161]
Tissue Inhibitor of Metalloprotease 1, TIMP1 CM of cultured mouse NG2 glia [26] Neuronal death and axonal plasticity [162]
Tissue Inhibitor of Metalloprotease 4, TIMP4 Gene expr. study of freshly sorted mouse NG2 glia [131];Gene expr. study of freshly sorted adult human NG2 glia [125] Tissue remodelling [163,164]
Neuromodulatory/
neurosupportive factors
Neuregulins Gene expr. study of cultured mouse NG glia [87];Gene expr. study and CM of cultured rat NG glia [165]
Synaptogenesis and synaptic plasticity [166], oligodendroglial and neuronal
survival [167,168]
Galanin mRNA and protein expr. in adult mouse NG2 glia [169] Modulation of neuronal activity [170]
Chromogranin B, Chgb Gene expr. study of freshly sorted adult human NG2 glia [125] Neurotransmission [171,172]
Chromogranin C, Chgc Gene expr. study of freshly sorted adult human NG2 glia [125] Neurite outgrowth [173] and angiogenesis [174].
Persephin, PSPN Gene expr. study of cultured mouse NG glia [87] Neuronal survival [175]
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Table 1. Cont.
Type of Signal Name and Abbreviation Exp. Approach (Source) Function
Morphogens
Wingless-type MMTV integration site family 4,
Wnt4 Gene expr. study of freshly sorted mouse NG2 glia [176] Synaptic plasticity [177]
Wingless-type MMTV integration site
family 7a, Wnt7a
Gene expr. study of freshly sorted mouse NG2 glia [176];
Gene expr. study and CM of cultured mouse NG2 glia [96];
In vivo expr. in embryonic NG2 glia [64]
Synaptic plasticity [178,179]; NG2 glia regulation of angiogenesis [96]
Wingless-type MMTV integration site
family 7b, Wnt7b
Gene expr. study of freshly sorted mouse NG2 glia [176];
Gene expr. study and CM of cultured mouse NG2 glia [96];
In vivo expr. in embryonic NG2 glia [64]
Synaptic plasticity [180]
Bone morphogenic protein 2, BMP2 Gene expr. study of freshly sorted adult human NG2 glia [125] Neuronal survival [181]
Bone morphogenic protein 7, BMP7 Gene expr. study of freshly sorted adult human NG2 glia [125] Maintainance of the identity of catecholaminergic neurons anddifferentiation of astrocytes [182]
Retinoic acid, RA Application of pharmacological inhibitors in cultured mouse NG2glia and in vivo assays in a model of rat spinal cord injury [99] NG2 glia regulation of axonal outgrowth [99]
Slit1 Gene expr. study of freshly sorted adult human NG2 glia [125] Regulation of adult SVZ neurogenesis [183], axon outgrowth and glial scarformation [184]
Inflammatory
cytokines/
immunomodulatory
factors
Interleukin 1 beta, Il-1b Gene expr. study of cultured mouse NG2 glia [87];Gene expr. study of cultured rat NG2 glia [93] Synaptic plasticity [185]
Interleukin 6, Il-6
Gene expr. study of cultured mouse NG2 glia [87];
Gene expr. study of cultured rat NG2 glia [93]
Gene expr. study of cultured mouse NG2 glia exposed to Il17 or
Tnf [158]
Regulation of adult neurogenesis [186,187], neuronal protection [187]
Interleukin 10, Il-10 Gene expr. study of cultured mouse NG2 glia [87];Gene expr. study and CM of cultured rat NG2 glia [93]
Neuronal and glial cell survival [88,188]. Anti-inflammatory
functions [189]
Transforming growth factor beta, Tgf-b
Gene expr. study of cultured mouse NG2 glia [87];
Gene expr. study of cultured rat NG2 glia and protein expr. in
mouse neonatal NG2 glia in vivo [65]
Neuronal survival and modulation of synaptic transmission [190]
Interleukin 1 Receptor Accessory
Protein, Il1rap Gene expr. study of freshly sorted mouse NG2 glia [131] Neuronal survival [191]
C-X-C Motif Chemokine Ligand 10, CxCl1 Gene expr. study of cultured mouse NG2 glia exposed to Il17 orTnf [158,192] Neuroinflammation [193]
C-X-C Motif Chemokine Ligand 10, CxCl10 CM of cultured mouse NG2 glia [97] Neuroinflammation [194]
C-X3-C Motif Chemokine Ligand 1, Cx3Cl1 CM of cultured mouse NG2 glia [97] Regulation of synapses activity and plasticity, brain functionalconnectivity and adult hippocampal neurogenesis [195]
C-C Motif Chemokine Ligand 7, Ccl7 Gene expr. study of cultured mouse NG2 glia exposed to Il17 [192] Neuroinflammation [196–198]
Granulocyte-Macrophage Colony Stimulating
Factor, GM-CSF or Csf2
Gene expr. study of cultured mouse NG2 glia exposed to Il17 or
Tnf [158] Neurotrophic function [199]
Exp: Experimental; expr: Expression; CM: Conditioned medium; FGF2: Fibroblast growth factor 2; NG2: Neuron-glia antigen 2.
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It is noteworthy that NG2 glia express and secrete a large repertoire of ‘neuroactive’ factors,
that can contribute to regulate neuronal survival, maturation and functions. The bioactivity and
functional relevance of some these signals have been validated by in vitro or in vivo approaches.
Namely, the neutralization of either brain derived growth factor (BDNF) or interleukin (Il)-10 in NG2
glia CM showed that these factors contribute to NG2 glia neuroprotective function in vitro [93].
Birey and colleagues showed that the specific knock-down of fibroblast growth factor 2 (FGF2)
in the NG2 glia of the prefrontal cortex suffices to induce depressive-like behaviors in mice,
and suggested that the loss of this signal mediates the effects of NG2 cell ablation on glutamatergic
transmission [87]. Similarly, by pharmacological and lentiviral inhibition of the retinoic acid
(RA) synthesis, Goncalves et al., showed that NG2 glia support axon growth and regeneration by
contributing to the conversion of retinal to RA [99].
The enrichment of ECM components and matrix metalloproteases (Table 1) suggests unique
interactions of NG2 glia with the ECM compared with other CNS cell types, and specific roles in
tissue maintenance and remodeling. Beside this, the regulation of ECM integrity and composition
is important for neurotransmitter receptor clustering at synapses [200,201]. Of note, a relatively
large repertoire of cell adhesion and ECM-associated molecules expressed by NG2 glia are well
known secreted pro-synaptogenic factors and synaptic organizers (e.g., thrombospondins, cerebellin 1,
olfactomedin 2, neurexophilin 1, neuronal pentraxin 2). These components may be instrumental to
build and maintain neuron-to-NG2 glia synaptic contacts. However, since NG2 glia processes have
been observed in close apposition to neuronal dendrites and somata or interdigitating within the
synaptic cleft of neuron-to-neuron synapses, this enrichment may be also related to a role of NG2
glia in neuronal synaptogenesis and synaptic plasticity. Similarly, ECM molecules expressed by NG2
glia (i.e., brevican, versican, tenascin R) importantly contribute to the assembly, maintenance and
function of the nodes of Ranvier [46], thereby suggesting a specific NG2 glia contribution to neuronal
maturation and action potential transmission.
In this context, recent data indicated that the NG2 chondroitin sulfate proteoglycan, whose
expression is restricted to NG2 glia among the neural cell types, can serve as a polyvalent regulator
of neuronal synaptic activity and action potential conduction. Sakry et al. [98] showed that the
ectodomain of the NG2 protein, constitutively released from the NG2 glia surface into the ECM by
the ADAM10 secretase, influences AMPA receptor currents and kinetics at glutamatergic synapses of
cortical pyramidal neurons. Moreover, the pharmacological inhibition of NG2 cleavage and release
from NG2 glia resulted in a large reduction of NMDAR-dependent, long-term potentiation (LTP) at
these synapses, indicating a specific role of NG2 in synaptic plasticity [98]. A further neuromodulatory
function of NG2 has been attributed to its intracellular domain that regulates the expression of
prostaglandin D2 synthase, a secreted enzyme that catalyzes the conversion of prostaglandin H2 to the
neuromodulatory form prostaglandin D2 [154]. Finally, in the injured spinal cord, secreted NG2 has
been observed to block action potential conduction at the nodes of Ranvier [202].
Transforming growth factor β (TGF-β) and Wingless-type MMTV integration site family 7 (Wnt7)
have recently been shown to mediate NG2 glia pro-angiogenetic effects in vivo. The pharmacological
inhibition of TGF-b signaling abolished the effect of NG2 glia CM on endothelial cell expression of tight
junction proteins in vitro. Consistently, the specific ablation of TGF-b1 in NG2 glia resulted in cerebral
hemorrhage and loss of blood brain barrier integrity in neonatal mice [65]. Similar approaches have
been used by Yuen et al. [96] to demonstrate that NG2 glia-derived Wnt7 mediates their pro-angiogenic
effects in vitro.
Notably, as a part of their plastic nature, NG2 glia dynamically modulate the expression/secretion
of specific signals in response to external factors. Importantly, signals inducing NG2 glia depolarization
reportedly affected their secretion. Exposure to GABA largely increased the production and secretion
of BDNF from adult rat NG2 glia [113]. Consistently, the application of a moderate intensity static
magnetic field, with its associated electric field, on human NG2 glia cultures resulted in increased
secretion of BDNF and neurotrophin 3 (NT-3) [114]. The release of the NG2 ectodomain from NG2
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glia was augmented by treatments with depolarizing agents or glutamate in vitro [98]. Along this
line, the expression of the neuromodulatory/neuroprotective peptide galanin significantly increased
in NG2 glia upon experimental cortical spreading depression [169]. These observations suggest that
activity dependent/synapse-mediated signals converging on NG2 glia may dynamically regulate their
secretory activity and homeostatic functions.
In conclusion, although the repertoire of factors expressed/secreted by NG2 glia has not yet been
explored in depth, these findings clearly indicate that they can serve as providers of relevant signals
for neighboring cells—in particular for neurons—in a context-dependent manner.
6. NG2 Glia Upon Central Nervous System Injury and Stress
The cellular roles of NG2 glia upon pathological conditions remain largely unclear. Notably,
in vivo/in vitro exposure to different kinds of stresses or injury-related signals remarkably affects
NG2 glia expression profile and secretion. Some of these changes can be interpreted as compensatory
attempts aimed at sustaining cell survival/functions and restoring the homeostasis. For example,
early after an acute brain injury, such as an ischemic event, BDNF protein expression largely
increased in NG2 glia, likely amplifying their neuroprotective potential [113]. However, when the
exposure to danger signals or stresses takes place over longer periods, gene expression/secretion
alterations in NG2 glia make them sustain or even worsen the pathological condition. In vivo
exposure to chronic stress induces profound transcriptional alterations in NG2 glia in specific brain
regions (i.e., prefrontal cortex and nucleus accumbens [87,203]), and largely reduces the levels
of growth factors (i.e., FGF2) and neurotrophins (i.e., NGF and NT4/5) [87]. After prolonged
cerebral hypoperfusion stress, perivascular NG2 glia in the adult white matter increased matrix
metalloprotease 9 (MMP9) expression and contributed to blood brain barrier opening [67]. Treatment
with sublethal concentrations of the inflammatory cytokine Il-1β also increased MMP9 secretion by
cultured NG2 glia [67]. Similarly, exposure to Il-17 or Tnf increased MMP9 and MMP3 expression
and elicited a robust inflammatory response in cultured NG2 glia [158]. Consistently, sustained Il-17
signaling in NG2 glia incorporated these cells in the inflammatory pathogenesis of experimental
autoimmune encephalomyelitis (EAE) [158]. Complementarily, experimental attenuation of NG2 glia
proliferative response after spinal cord lesion was associated with reduced accumulation of activated
microglia/macrophages, diminished astrocyte hypertrophy, and eventually with the establishment of
a post-injury environment more supportive for tissue repair [204]. This suggests a role for NG2 cells in
orchestrating reactive gliosis.
Thus, beyond their role in myelin repair and glial scar formation [205], depending on the
circumstances, NG2 glia have been observed either to limit CNS damage or to actively contribute
to neuroinflammation/neurotoxicity, as also shown in Amyotrophic Lateral Sclerosis models [206].
To further increase the complexity of this scenario, consistent with previous findings [207,208], in vivo
two-photon imaging analyses revealed an assortment of distinct NG2 glia reactions to injury, with some
cells starting migration toward the lesion site, others entering cell cycle, and others displaying only
hypertrophy and morphological changes [31,86]. Single-cell messenger-RNA (mRNA) profiling
of NG2 glia after focal cerebral ischemia also identified at least three subpopulations of cells that
could be distinguished according to changes in their expression patterns [19]. Such behavioral and
molecular heterogeneity suggests the existence of diverse NG2 glia subsets which respond differently
to CNS injury.
7. Concluding Remarks and Open Issues
In this review, we have summarized the advancements obtained over recent years toward the
understanding of the roles of NG2 glia in CNS homeostasis and development. Though it is widely
accepted that these cells act as precursors for OLs in the developing and mature CNS, accumulating
evidence indicates that NG2 glia (or subsets of NG2 glia) can exert additional/alternative functions.
Recent studies have shown that NG2 glia establish physical interactions with the other CNS cell types,
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are integrated in neuronal networks, and possess a repertoire of ion channels and neurotransmitter
receptors apt to constantly monitor the activity of the surrounding neurons. In addition to operating
as sensors, NG2 glia have features that are expected for active modulators of the neuronal activity,
including the expression and release of a complex array of neuromodulatory and neuroprotective
factors. Consistently, cell ablation strategies targeting NG2 glia demonstrate that the maintenance of
their density contributes to the normal function and development of different CNS regions, beyond
their role in myelination.
Although showing some similarities with astrocytes—as regards their physical/functional
relationships with neurons and blood vessels, and to a certain extent, gene expression—data available
so far point to a distinct contribution of these two glial cell types in CNS homeostasis. NG2 glia
specificity relies on the ability to monitor, and perhaps modulate, the activity of the neuronal networks
with a resolution in time, space and intensity that cannot be achieved by astroglia. This appears to be
related to NG2 glia typical morphology (with fine processes establishing contacts at well defined sites
onto neurons) and functional properties (including the ability to sense neuronal activity at the quantal
level through neuron-to-NG2 glia synapses). Further, since the roles/features of NG2 glia described
above do not emerge as the by-product of the metabolic/gene expression control of typical progenitor
functions (i.e., proliferation and differentiation in myelin-producing cells), they cannot simply be
interpreted as epiphenomena (i.e., secondary functions) of the role of NG2 glia as OL precursors.
Thus, NG2 glia not only represent a transitional stage along the oligodendroglial lineage, but rather,
a specific glial cell type endowed with typical properties and functions.
However, this field of research is still in its infancy and the mechanistic nature of NG2 glia
functions beyond re-/myelination remains still unclear. Further efforts are needed to overcome the
limitations of the experimental strategies employed so far, and to identify the molecular and cellular
processes subserving NG2 glia participation in CNS homeostasis, ontogeny, and disease. Namely,
the in vivo NG2 glia ablation approaches showed important intrinsic caveats, e.g., the achievement
of a partial and transient cell ablation due to the fast repopulation of NG2 glia; region-specific
differences in the ablation efficiency due to different cell cycle dynamics and repopulation efficiency
of NG2 glia in distinct CNS areas [87]; selective/predominant ablation of specific NG2 glia subsets
(i.e., those that are more prone to enter cell cycle; [42,88]); possible interference/superimposition
of the reactions of other CNS cell types responding to NG2 glia loss [88]. Such limitations
restrict the time window/extent/types of phenotypes that could be attributed to NG2 glia loss,
and may also hamper investigation into the underlying molecular mechanisms. Recent studies have
started to unveil the cellular processes through which NG2 glia can transfer functionally relevant
signals (i.e., conventional vesicle release, exosome shedding, cleavage of extracellular fragments of
membrane-bound proteins). Targeting such processes (e.g., by a genetic-based deletion of specific
components of the secretory/shedding/cleavage machineries in NG2 glia) may provide an alternative
experimental setting to unveil the impact and relevance of NG2 glia to other cell types communication.
Further, validation, perhaps using cell type-specific subtractive/deletion approaches (as in [87]), of
the effects exerted by NG2 glia-derived factors in vivo is required to define the regulatory signals
that are truly unique in mediating NG2 glia functions. The identification of such factors has recently
taken advantage of RNA sequencing technologies [131]. The progresses of these strategies will make
it possible to study the transcriptomic landscape at the single cell level, thereby possibly unveiling
also the heterogeneous nature of NG2 glia [209]. Moreover, since these cells establish contacts with
neurons and other cell types at specific sites along processes and somata, and local mRNA localization
and translation may be instrumental for their crosstalk (as recently shown for astrocytes, [210]),
we envisage that novel approaches of spatial transcriptomics may be also fruitfully exploited to
perform high-throughput quantifications while preserving spatial information about the subcellular
localization of the analysed transcripts [211].
Indeed, such studies may also open translational perspectives for the implementation of the
endogenous neurosupportive/neuroprotective potential of the CNS. In this context, more research is
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also needed to fully understand NG2 glia participation in pathology. A detailed and comprehensive
examination of NG2 glia behaviors/molecular changes upon lesion will likely unveil some elements
of cell heterogeneity (see above). Indeed, diverse NG2 glia subpopulations have also been described in
the intact CNS based on their origin, proliferative activity, division modality, differentiation potential,
expression of diverse transcription factors, Ca2+-binding molecules, neurotransmitter receptors,
and ionic currents [5,23,48,69,212]. Thus, it is conceivable that subsets of functionally specialized
NG2 glia may be differentially tailored to contribute to distinct aspects of CNS homeostasis, including
oligodendrogenesis and additional/alternative functions. This issue deserves to be the focus of future
investigations, and adds a further element of complexity on the functioning of this fascinating cell type.
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